Dr. Sharmila D. Dissanaike, MD

Dr. Dissanaike practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Dissanaike's NPI, 1639286123, was assigned on August 23, 2006. Dr. Dissanaike graduated from University of Sydney Faculty of Medicine in 2000. Dr. Dissanaike's Texas license number on file is M7952.

Dr. Dissanaike's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Dissanaike's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Dissanaike to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dissanaike practices, 2 sites in all. Vendor and product names are available with a free account.

Surgical critical care is Dr. Dissanaike's primary specialty in the NPI Registry, under taxonomy code 2086S0102X. Dr. Dissanaike is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Dissanaike's licenses on file in 3 states: Texas, New Mexico and Washington.

Dmand AI lists abdominal adhesion surgery, appendectomy, colon removal, gallbladder removal, gastrointestinal obstruction, groin hernia surgery, multiple traumatic injuries and non-surgical back problems among the conditions Dr. Dissanaike treats.

CMS data shows 100 Medicare services from Dr. Dissanaike across 2 procedure codes in 2023, for 37 Medicare patients. Medicare paid $4,348 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Dr. Dissanaike in 2024. The largest group is 75 to 84, with 15 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dissanaike's median patient age at 55, with 38% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Dissanaike for performance year 2024, reported through an alternative payment model (APM). Dr. Dissanaike accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 104 papers to Dr. Dissanaike, published from 2006 to 2025. 2022 was the busiest year, with 10. The most frequent topics are Burns, Length of Stay and Soft Tissue Infections. Dr. Dissanaike has published most often in J Burn Care Res. Dr. Dissanaike's most frequent co-authors are John Anthony Griswold, MD, Yana Puckett, MD and Adel Alhaj Saleh, MD.

Dmand AI links Dr. Dissanaike to 2 clinical trials. Conditions studied include Burns, Obesity and Wound Infection. Texas Tech University Health Sciences Center sponsors the most, 2.

CMS Open Payments shows 125 general payments to Dr. Dissanaike from 39 drug and device companies from 2016 to 2024. Ownership or investment make up the largest share, 91% of the total. Heron Therapeutics, Inc. paid the most, $841,262.

Dmand AI lists 2 awards for Dr. Dissanaike, most recently CMS Stage 1 2012 in 2012.

Dr. Dissanaike graduated from University of Sydney Faculty of Medicine in 2000. Dr. Dissanaike is a member of ACS.

Dr. Dissanaike is in network with 20 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.